Mizuho raised the firm’s price target on Herbalife to $11 from $10 and keeps a Neutral rating on the shares. Th firm has more confidence that the company’s EBITDA is bottoming. Following over two years of headwinds, Herbalife’s improving execution increasingly suggests the largest sales weakness has passed, the analyst tells investors in a research note. The firm says the company’s North America distributors growth amid new initiatives, and stabilizing declines in Nielsen weight management segment, return to growth in China, and improving international productivity are positives.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLF:
- Herbalife’s (NYSE:HLF) Restructuring Efforts May Be Bearing Fruit
- Herbalife Shareholders Decide on Board and Incentives at AGM
- Herbalife rasies FY24 adjusted EBITDA view to $550M-$590M from $540M-$580M
- Herbalife sees Q2 adjusted EBITDA $140M-$160M vs. $169.6M y/y
- Herbalife reports Q1 EPS 49c, consensus 35c
Questions or Comments about the article? Write to editor@tipranks.com